Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
US Army
Fish and Richardson
Daiichi Sankyo
Mallinckrodt
Novartis
Citi
US Department of Justice
McKesson
Baxter

Generated: October 18, 2017

DrugPatentWatch Database Preview

FLURBIPROFEN Drug Profile

« Back to Dashboard

Which patents cover Flurbiprofen, and what generic Flurbiprofen alternatives are available?

Flurbiprofen is a drug marketed by Teva, Ivax Sub Teva Pharms, Pliva, Aurolife Pharma Llc, Mylan, Sun Pharm Inds Inc, Theragen, and Bausch And Lomb. and is included in nine NDAs.

The generic ingredient in FLURBIPROFEN is flurbiprofen sodium. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the flurbiprofen sodium profile page.

Summary for Tradename: FLURBIPROFEN

US Patents:0
Applicants:8
NDAs:9
Suppliers / Packagers: see list8
Bulk Api Vendors: see list79
Clinical Trials: see list34
Patent Applications: see list7,252
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FLURBIPROFEN at DailyMed

Pharmacology for Tradename: FLURBIPROFEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva
FLURBIPROFEN
flurbiprofen
TABLET;ORAL074405-002May 24, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
Pliva
FLURBIPROFEN
flurbiprofen
TABLET;ORAL074647-002Apr 1, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Ivax Sub Teva Pharms
FLURBIPROFEN
flurbiprofen
TABLET;ORAL074411-002May 31, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
Sun Pharm Inds Inc
FLURBIPROFEN
flurbiprofen
TABLET;ORAL075058-001Apr 27, 2001ABRXNoNo► Subscribe► Subscribe► Subscribe
Aurolife Pharma Llc
FLURBIPROFEN
flurbiprofen
TABLET;ORAL074448-001Jul 28, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
Theragen
FLURBIPROFEN
flurbiprofen
TABLET;ORAL074560-002May 16, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva
FLURBIPROFEN
flurbiprofen
TABLET;ORAL074405-001May 24, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
Ivax Sub Teva Pharms
FLURBIPROFEN
flurbiprofen
TABLET;ORAL074411-001May 31, 1995DISCNNoNo► Subscribe► Subscribe► Subscribe
Pliva
FLURBIPROFEN
flurbiprofen
TABLET;ORAL074647-001Apr 1, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva
FLURBIPROFEN
flurbiprofen
TABLET;ORAL074431-001May 31, 1995ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Dow
Merck
Daiichi Sankyo
Fish and Richardson
US Department of Justice
Queensland Health
Johnson and Johnson
McKinsey
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot